Development of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration During Anti–Vascular Endothelial Growth Factor Treatment

To identify the risk factors of intraretinal fluid (IRF) development during anti-vascular endothelial growth factor (VEGF) treatment for neovascular age-related macular degeneration (AMD).Retrospective cohort study.A total of 425 treatment-naïve patients with neovascular AMD who completed 24 months of follow-up were enrolled. All patients were treated with an initial series of 3 monthly loading doses of anti-VEGF injections, followed by further...